Evidence map›Paper›PMID 30625150›Full record

ArticlePloS one2019

Optimization of T-DNA architecture for Cas9-mediated mutagenesis in Arabidopsis.

Baptiste Castel, Laurence Tomlinson, Federica Locci, Ying Yang, Jonathan D G Jones

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 169 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Baptiste CastelThe Sainsbury Laboratory, Norwich Research Park, Norwich, United Kingdom.ORCID 0000-0002-2722-0228
Laurence TomlinsonThe Sainsbury Laboratory, Norwich Research Park, Norwich, United Kingdom.ORCID 0000-0002-5192-8699
Federica LocciThe Sainsbury Laboratory, Norwich Research Park, Norwich, United Kingdom.
Ying YangThe Sainsbury Laboratory, Norwich Research Park, Norwich, United Kingdom.
Jonathan D G JonesThe Sainsbury Laboratory, Norwich Research Park, Norwich, United Kingdom.
Norwich Research Park · GBUniversity of Nebraska–Lincoln · US

Funding

Biotechnology and Biological Sciences Research Council BB/K003550/1Biotechnology and Biological Sciences Research Council BB/L014130/1Biotechnology and Biological Sciences Research Council BB/M003809/1
6 · The paper itself

Abstract

Bacterial CRISPR systems have been widely adopted to create operator-specified site-specific nucleases. Such nuclease action commonly results in loss-of-function alleles, facilitating functional analysis of genes and gene families We conducted a systematic comparison of components and T-DNA architectures for CRISPR-mediated gene editing in Arabidopsis, testing multiple promoters, terminators, sgRNA backbones and Cas9 alleles. We identified a T-DNA architecture that usually results in stable (i.e. homozygous) mutations in the first generation after transformation. Notably, the transcription of sgRNA and Cas9 in head-to-head divergent orientation usually resulted in highly active lines. Our Arabidopsis data may prove useful for optimization of CRISPR methods in other plants.

Indexed as

Agrobacterium tumefaciensArabidopsisCRISPR-Cas SystemsDNA, BacterialGene EditingGenetic VectorsMutagenesis, Site-DirectedPlants, Genetically ModifiedPlasmidsPromoter Regions, GeneticRNA, Guide, CRISPR-Cas SystemsTransformation, BacterialDNA, BacterialRNA, Guide, CRISPR-Cas SystemsT-DNA

Identifiers

PMID30625150
PMCPMC6326418
OpenAlexW2952594972

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.